Abstract
Cancer related pelvic pain severely impairs the quality of life and can be resistant to a variety of interventions. Neuromodulation is emerging as a potential avenue to manage pain and improve quality of life. Unlike Spinal cord stimulators (SCS), dorsal root ganglion (DRG) stimulation targets focal areas and is an attractive target for neurostimulation. Over the past decade, DRG stimulation has become a part of the armamentarium to effectively treat discrete areas of pain particularly resistant to other interventional modalities. A case series showed significant analgesic benefit from DRG stimulation with L1/S2 lead placement in patients with chronic pelvic pain resistant to a variety of other therapies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
